‘Serious humanitarian crises’ in South Asia as floods affect over 16 million peole

Indian residents wade through flood waters in Balurghat in West Bengal on Thursday. (AFP)
Updated 19 August 2017

‘Serious humanitarian crises’ in South Asia as floods affect over 16 million peole

KATMANDU/GUWAHATI: More than 16 million people have been affected by floods in South Asia, aid workers and officials said, with heavy rains and damaged roads hampering relief efforts amid severe food shortages and a growing risk of waterborne diseases.
Heavy monsoon rains in Nepal, Bangladesh and India have killed more than 343 people, officials and aid workers said.
“This is fast becoming one of the most serious humanitarian crises this region has seen in many years,” said Martin Faller, deputy regional director for Asia Pacific at the International Federation of Red Cross and Red Crescent Societies.
“Millions of people face severe food shortages and disease. We fear (it) will get worse in the days and weeks ahead.”
More than a third of Bangladesh and Nepal have been flooded, Faller said.
In Nepal, 27 of 75 districts were either submerged or hit by landslides, leaving villages and communities stranded without food, water and electricity.
Home Ministry official Shankar Acharya said 131 people had been killed and 30 were missing.
“We need donors’ assistance and support from social organizations,” an official statement said.
Aid workers are rushing to deliver tarpaulins for temporary shelter, food and water, said Dev Ratna Dhakhwa, secretary general of the Nepal Red Cross Society.
Residents face “severe food shortages,” as food crops have been wiped out in the worst floods in 15 years, he said.
The risk of a “significant public health crisis” from waterborne diseases such as cholera is also high, charity WaterAid said.
In Bangladesh, flood levels have reached record highs. At least 56 people have been killed and about 4 million are affected, the Red Crescent said Thursday.
The situation could get worse as swollen rivers carry rainwater from neighboring India downstream into the low-lying and densely populated country.
“The immediate situation is extremely desperate,” Save the Children Director Mark Pierce said in a statement.
“The sheer volume of water is also making it really difficult to access some of the communities most in need.”
In India, more than 11 million people have been affected in four states across the north and east, with at least 156 killed.
“These are the worst floods in Assam in a decade,” Keshab Mahanta, relief and rehabilitation minister, told the Thomson Reuters Foundation.
Relief operations have been hampered, even as food packets are being dropped from helicopters in the worst affected areas.
In a makeshift relief camp in Kaliabor, 160 km east of Guwahati city, families said they had not received any aid.
“We are practically starving, with no government supplies reaching us,” said Arunima Dutta, mother of three, who is sheltering from the disaster with hundreds of others.
Residents are also at risk of contracting diseases such as malaria and Japanese encephalitis, the Red Cross warned.
India’s meteorological department is forecasting more heavy rain for the region in the coming days.
“Though we come to expect these rains every year, this year is particularly severe,” Save the Children India manager Murali Kunduru said.

UK testing ibuprofen as coronavirus treatment

Updated 54 min 26 sec ago

UK testing ibuprofen as coronavirus treatment

  • Anti-inflammatory properties of the drug could treat breathing difficulties

LONDON: Scientists in London are running a drugs trial to test if ibuprofen is an effective treatment for hospital patients with COVID-19.

The teams at Guy’s and St. Thomas’s hospital and researchers from King’s College London believe that the anti-inflammatory properties of the drug could treat breathing difficulties.

Struggling with breathing, and the demand on ventilators in intensive care units, have been two major challenges regarding COVID-19. Researchers hope that the low-cost painkiller could reduce the reliance on ventilators.

The trial, called Liberate, will treat half the patients with ibuprofen on top of their usual care. The researchers will use a special formulation of ibuprofen that some people already take for arthritis.

Previous studies in animals have shown that it might treat acute respiratory distress syndrome, which is one of the complications caused by severe COVID-19 infections.

Prof. Mitul Mehta from the King’s College London team said: “We need to do a trial to show that the evidence actually matches what we expect to happen.”

At the onset of the pandemic, there were concerns that ibuprofen would aggravate the infection, with French Health Minister Oliver Veran advising patients to take paracetamol instead.